Contribution of JAK2 mutations to T-cell lymphoblastic lymphoma development-Reference-Cited by-同舟云学术

Contribution of JAK2 mutations to T-cell lymphoblastic lymphoma development

Published:2015-07-28 Issue:1 Volume:30 Page:94-103
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Roncero A M,López-Nieva P,Cobos-Fernández M A,Villa-Morales M,González-Sánchez L,López-Lorenzo J L,Llamas P,Ayuso C,Rodríguez-Pinilla S M,Arriba M C,Piris M A,Fernández-Navarro P,Fernández A F,Fraga M F,Santos J,Fernández-Piqueras J

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

http://www.nature.com/articles/leu2015202.pdf

Reference57 articles.

1. de Leval L, Bisig B, Thielen C, Boniver J, Gaulard P . Molecular classification of T-cell lymphomas. Crit Rev Oncol Hematol 2009; 72: 125–143.

2. Aifantis I, Raetz E, Buonamici S . Molecular pathogenesis of T-cell leukaemia and lymphoma. Nat Rev Immunol 2008; 8: 380–390.

3. Van Vlierberghe P, Ferrando A . The molecular basis of T cell acute lymphoblastic leukemia. J Clin Invest 2012; 122: 3398–3406.

4. Burkhardt B . Paediatric lymphoblastic T-cell leukaemia and lymphoma: one or two diseases? Br J Haematol 2010; 149: 653–668.

5. Bonn BR, Rohde M, Zimmermann M, Krieger D, Oschlies I, Niggli F et al. Incidence and prognostic relevance of genetic variations in T-cell lymphoblastic lymphoma in childhood and adolescence. Blood 2013; 121: 3153–3160.

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic potential of anticancer activity of nitrogen-containing heterocyclic scaffolds as Janus kinase (JAK) inhibitor: Biological activity, selectivity, and structure–activity relationship;Bioorganic Chemistry;2024-11

2. Dissecting the multifaceted roles of autophagy in cancer initiation, growth, and metastasis: from molecular mechanisms to therapeutic applications;Medical Oncology;2024-06-20

3. Phosphoproteomic Analysis Reveals a Different Proteomic Profile in Pediatric Patients With T-Cell Lymphoblastic Lymphoma or T-Cell Acute Lymphoblastic Leukemia;Frontiers in Oncology;2022-07-08

4. Comprehensive view on genetic features, therapeutic modalities and prognostic models in adult T-cell lymphoblastic lymphoma;Blood Science;2022-07

5. Janus Kinase Signaling: Oncogenic Criminal of Lymphoid Cancers;Cancers;2021-10-14